NCT04263714

Brief Summary

Generally, resistance exercise increases muscle mass and strength, and fatigue resistance. How resistance exercise achieves these adaptations remains understudied, but what is known is that skeletal muscle translates the physical and biochemical stresses of resistance exercise into morphological and metabolic adaptations. While resistance exercise activates signaling pathways (i.e., proteins) that increase the synthesis of specific proteins to cause adaptations, thousands of proteins are likely involved, and their interactions are complicated. The investigators aim to study these processes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 11, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
7 months until next milestone

Results Posted

Study results publicly available

November 21, 2024

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

3.2 years

First QC Date

February 5, 2020

Results QC Date

August 14, 2024

Last Update Submit

November 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Acute Muscle Protein Synthesis

    Myofibrillar and intracellular enrichments of L-\[ring- 13C6\] phenylalanine will be measured. MPS will be calculated using the precursor-product equation: MPS =(\[E2b-E1b\]/\[Eic x t\]) x 100. Eb represents the enrichment of bound myofibrillar protein, Eic is the average intracellular enrichment between two biopsies, and t is the tracer incorporation time in h. As we will employ 'tracer naïve' participants (had not previously participated in a study protocol where L-\[ring- 13C6\] phenylalanine was infused), a pre-infusion blood sample will be used for the calculation of resting myofibrillar MPS. The outcomes measure will be expressed as a percentage change of MPS relative to the baseline measure. i.e. intracellular enrichment of L-\[ring- 13C6\] phenylalanine relative to the baseline (resting) period.

    Pre exercise (resting) to 3 hours post-exercise

Study Arms (1)

Exercise

EXPERIMENTAL

All subjects will perform both aerobic and resistance exercise

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Aerobic exercise and resistance exercise

Exercise

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- between the ages of 18 and 30 years

You may not qualify if:

  • Smoker or user of tobacco products;
  • High physical activity
  • Have health problems such as: renal or gastrointestinal disorders, metabolic disease, heart disease, vascular disease, rheumatoid arthritis, diabetes, poor lung function, uncontrolled blood pressure, dizziness, thyroid problems, or any other health conditions for which you are being treated that might put you at risk for this study;
  • Taking anti-diabetic, anti-inflammatory, platelet inhibitor, or anti-coagulant medications;
  • Use of an investigational drug product within the last 30 days;
  • Have participated in an infusion protocol in the last year; or
  • Do not understand English or have a condition the PI believes would interfere with a participants' ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put someone at undue risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Metabolism Research Laboratory, McMaster Univeristy

Hamilton, Ontario, L8S 4K1, Canada

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr. Stuart Phillips
Organization
McMaster University

Study Officials

  • Stuart Phillips, PhD

    McMaster University, Department of Kinesiology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Aerobic and resistance exercise
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 5, 2020

First Posted

February 11, 2020

Study Start

April 1, 2020

Primary Completion

July 1, 2023

Study Completion

May 1, 2024

Last Updated

November 21, 2024

Results First Posted

November 21, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

All data will be deposited on OSF

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
At the time of publication
Access Criteria
Everyone can access

Locations